Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2017
Home
2017
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Receives $947K R&D Tax Credit
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Date of Annual General Meeting
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Appoints Dr Martin Cross as Non-Executive Director
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Notice of Annual General Meeting/Proxy form
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Annual Report to Shareholders
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Consolidation/split – CDY
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Proposed Consolidation of Securities
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appendix 4C – quarterly
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Announcement of buy-back – Appendix 3C
Prev page
1
2
3
4
5
Next page
